The University of Chicago Header Logo

Connection

Girish Venkataraman to Aged, 80 and over

Back to Details
This is a "connection" page, showing publications Girish Venkataraman has written about Aged, 80 and over.
Girish Venkataraman
Connection Strength
0.665
Aged, 80 and over
  1. Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with =5% blasts: An International TP53 Investigators Network (iTiN) study. Cancer. 2026 Jan 01; 132(1):e70210.
    View in: PubMed
    Score: 0.111
  2. Karyotypic clonal fraction predicts adverse outcome in TP53-mutated myeloid neoplasms: an International TP53 investigators Network (iTiN) study. J Clin Pathol. 2025 Aug 18; 78(9):629-635.
    View in: PubMed
    Score: 0.108
  3. Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms. Br J Haematol. 2025 Apr; 206(4):1103-1108.
    View in: PubMed
    Score: 0.103
  4. Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 06 18; 14(1):99.
    View in: PubMed
    Score: 0.100
  5. Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases. Mod Pathol. 2011 Mar; 24(3):355-66.
    View in: PubMed
    Score: 0.039
  6. Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer. Prostate. 2007 Oct 01; 67(14):1524-36.
    View in: PubMed
    Score: 0.031
  7. Erythroblastic Sarcoma in Adults and Children: Different Pathways to the Same Destination. Mod Pathol. 2025 Aug; 38(8):100716.
    View in: PubMed
    Score: 0.026
  8. Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms. Blood Adv. 2024 11 26; 8(22):5796-5805.
    View in: PubMed
    Score: 0.026
  9. Incidental detection of non-melanoma neoplasms in sentinel lymph node biopsy for melanoma staging: A retrospective case series. J Cutan Pathol. 2024 Dec; 51(12):1000-1007.
    View in: PubMed
    Score: 0.025
  10. Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. Blood Cancer J. 2021 02 18; 11(2):39.
    View in: PubMed
    Score: 0.020
  11. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma. Blood Adv. 2019 10 08; 3(19):2790-2799.
    View in: PubMed
    Score: 0.018
  12. Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Mod Pathol. 2016 10; 29(10):1173-82.
    View in: PubMed
    Score: 0.014
  13. De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. Am J Hematol. 2016 Jun; 91(4):395-9.
    View in: PubMed
    Score: 0.014
  14. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol. 2013 Jun; 37(6):816-26.
    View in: PubMed
    Score: 0.012
  15. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011 May 05; 117(18):4726-35.
    View in: PubMed
    Score: 0.010
  16. EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010 Mar; 34(3):405-17.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.